Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.62 USD | +5.44% | +3.69% | +14.93% |
02:00pm | Oppenheimer Initiates Capricor Therapeutics at Outperform Rating | MT |
May. 13 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.93% | 178M | |
+8.29% | 114B | |
+10.21% | 104B | |
-11.90% | 22.41B | |
+0.47% | 22.28B | |
-5.48% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- CAPR Stock
- News Capricor Therapeutics, Inc.
- Transcript : Capricor Therapeutics, Inc. - Special Call